Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestors
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
RPRX
Royalty Pharma plc RPRX
$54.27
โ–ผ -0.76% 24H
24.8432.6040.3548.1155.872020-062021-122023-062024-122026-06

About

Royalty Pharma plc is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in the life sciences sector. The company acquires royalties entitling it to payments based on net sales of approved therapies and development-stage product candidates, partnering with innovators from academโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees100
TickerRPRX

Statistics

Market Cap$24.08B
Revenue (TTM)$2.38B
Net Income$770.9M
Net Margin32.4%
EPS$1.78
P/E28.69
P/S12.86
P/B3.51
EV/EBITDA22.08
ROE13.8%
Dividend Yield1.71%
Price$54.27

Data: Twelve Data ยท Revenue = mcap / P/S

Royalty Pharma plc (RPRX) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap